News - Sitavig

Filter

Current filters:

Sitavig

Popular Filters

BioAlliance Pharma signs deal with EMS for Sitavig in Brazil

BioAlliance Pharma signs deal with EMS for Sitavig in Brazil

26-06-2014

French oncology specialist BioAlliance Pharma SA has announced a license agreement for Sitavig (acyclovir…

Antibiotics and Infectious diseasesBioAlliance PharmaBrazilLicensingPharmaceuticalSitavig

BioAlliance Pharma licenses Sitavig to Innocutis in North America

19-03-2014

French drug developer BioAlliance Pharma has executed a licensing accord with the USA’s Innocutis Holdings…

Anti-viralsBioAlliance PharmaBiotechnologyInnocutis HoldingsLicensingNorth AmericaSitavig

BioAlliance Pharma' Sitavig shows marked efficacy in treating cold sores

29-05-2013

French drugmaker BioAlliance Pharma (Euronext Paris: BIO) has presented positive results of the pharmacokinetic…

Anti-viralsBioAlliance PharmaPharmaceuticalResearchSitavig

BioAlliance Pharma's Sitavig OKed by US FDA for Herpes labialis

16-04-2013

French drugmaker BioAlliance Pharma (Euronext Paris - BIO) has received marketing authorization from…

Anti-viralsBioAlliance PharmaNorth AmericaPharmaceuticalRegulationSitavig

BioAlliance gains registration of Sitavig in eight European countries

20-12-2012

French biotech firm BioAlliance Pharma (Euronext Paris: BIO) has announced the approval of Sitavig (acyclovir…

Anti-viralsBioAlliance PharmaBiotechnologyEuropeRegulationSitavig

Teva gets rights to BioAlliance's Sitavig in Israel

14-06-2012

French drugmaker BioAlliance Pharma (Euronext Paris: BIO) has signed an exclusive license agreement for…

Anti-viralsBioAlliance PharmaLicensingPharmaceuticalRest of the WorldSitavigTeva Pharmaceutical Industries

BioAlliance's Sitavig NDA "receivable" by US FDA

30-05-2012

French biotech firm BioAlliance Pharma (Euronext Paris: BIO) has announced the receivability of its Sitavig…

Anti-viralsBioAlliance PharmaBiotechnologyNorth AmericaRegulationSitavigSitavir

Back to top